시장보고서
상품코드
1596902

정맥주사(IV) 용액 시장 규모, 점유율, 성장 분석 : 부문별 및 지역별 산업 예측(2024-2031년)

Intravenous Solutions Market Size, Share, Growth Analysis, By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrients (Carbohydrates, Parenteral Lipid Emulsion), By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 192 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정맥주사(IV) 용액(Intravenous Solutions) 시장 규모는 2022년 119억 9,000만 달러로 평가되었고, 2023년 129억 5,000만 달러에서 2031년에는 239억 6,000만 달러로 성장해, 예측기간(2024-2031년)의 CAGR은 8.0%로 추이하며 성장할 전망입니다.

만성 질환 유병률의 증가, 홈 헬스케어 서비스에 대한 수요 증가, 노인 인구의 급증으로 인해 전 세계 정맥주사(IV) 용액 시장은 견조한 성장세를 보이고 있습니다. 이러한 멸균 액체는 수분 공급, 영양 지원, 약물 및 전해질 투여 등 환자 치료에서 중요한 역할을 합니다. 특히 수액 장치의 기술 발전과 지속 가능한 제조 및 포장 방법으로의 업계 변화는 시장 확대를 더욱 촉진하고 있습니다. 그러나 엄격한 규제 요건, 높은 제조 비용, 신생 기업과 기존 기업 간의 경쟁 심화 등 성장에 걸림돌이 되는 장애물이 없는 것은 아닙니다. 이러한 장애물에도 불구하고, 특히 영양 정맥주사(IV) 용액에 대한 관심이 높아지고 개인 맞춤형 의약품 전략에 대한 수요가 증가하면서 새로운 기회가 생겨나고 있습니다. 시장이 진화함에 따라 이해관계자들은 이러한 복잡성을 헤쳐나가는 동시에 혁신과 변화하는 소비자 선호도를 활용하여 정맥주사(IV) 용액 부문에서 입지를 강화해야 합니다.

목차

소개

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 및 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제 조건 및 제한 사항

주요 요약

  • 세계 시장 전망
  • 공급 및 수요 동향 분석
  • 부문별 기회 분석

시장 역학 및 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인 및 기회
    • 억제요인 및 과제
  • Porter's Five Forces 분석 및 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 구매자의 협상력
    • 신규 참가업체의 위협
    • 공급기업의 협상력

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁도
  • 주요 투자 기회
  • 시장 생태계
  • 기술 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • PESTEL 분석
  • 거시경제지표
  • 공급망 분석
  • 가격 분석

정맥주사(IV) 용액 시장 규모 : 제품별

  • 완전 정맥 영양
  • 말초 정맥 영양

정맥주사(IV) 용액 시장 규모 : 영양소별

  • 탄수화물
  • 비타민과 미네랄
  • 단회 투여 아미노산
  • 비경구 지질 유제
  • 기타

정맥주사(IV) 용액 시장 규모 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아 태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아 태평양
  • 남미
    • 브라질
    • 기타 남미
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사 비교
  • 주요 기업 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업 시장 점유율 분석(2023년)
  • 주요 기업 프로파일
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 수익의 전년 대비 비교(2021-2023년)

주요 기업 프로파일

  • Akshar Pharma
  • Fresenius Kabi AG
  • MEDEVAC LIFESCIENCES PVT LTD
  • Pfizer, Inc.
  • LXIR MEDILABS PVT. LTD
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • B. Braun
  • Melsungen AG
  • Aishwarya Healthcare
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Health Care
  • ICU Medical, Inc.
  • Grifols SA
  • AptarGroup, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Amgen Inc.
  • Novartis AG

결론 및 권장사항

LYJ

Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).

The global intravenous (IV) solutions market is showing robust growth, primarily driven by an increase in chronic disease prevalence, heightened demand for home healthcare services, and a burgeoning elderly population. These sterile liquids serve crucial roles in patient care-providing hydration, nutritional support, and the administration of medications and electrolytes. Technological advancements, particularly in infusion devices, along with an industry shift towards sustainable manufacturing and packaging methods, are further propelling market expansion. However, the landscape is not without challenges; stringent regulatory requirements, high manufacturing expenses, and intensifying competition between emerging and established firms present obstacles to growth. Despite these hurdles, new opportunities are emerging, especially with a heightened focus on nutritional IV solutions and the rising demand for personalized medicine strategies. As the market evolves, stakeholders must navigate these complexities while capitalizing on innovation and shifting consumer preferences to enhance their positioning in the intravenous solutions sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Solutions Market Segmental Analysis

Global Intravenous Solutions Market is segmented by Product, Nutrients, and region. Based on Product, the market is segmented into Total Parenteral Nutrition, Peripheral Parenteral Nutrition. Based on Nutrients, the market is segmented into Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is experiencing significant growth due to the remarkable rise in home healthcare services. An increasing number of patients are opting for treatments in the comfort of their own homes, particularly those managing chronic conditions, which is driving the demand for home-based IV and infusion therapies. This shift not only enhances patient comfort but also improves treatment adherence, prompting healthcare professionals to expand their offerings of intravenous solutions specifically for home use. As a result, the market is witnessing a surge in demand for adaptable and convenient intravenous therapies that cater to the evolving preferences of patients.

Restraints in the Global Intravenous Solutions Market

The Global Intravenous Solutions market faces significant restraints primarily due to safety concerns and the potential for contamination during the administration or production of IV technologies. These issues can lead to increased regulatory scrutiny and challenges, ultimately hindering the widespread adoption of these solutions and stunting market growth. Furthermore, patients might experience side effects from specific intravenous therapies, which could cause hesitation among healthcare professionals in utilizing such products. This apprehension not only affects the confidence of providers but also contributes to a reluctance in recommending IV treatments, further impacting the overall trajectory of the market.

Market Trends of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is witnessing a significant trend towards home infusion therapy, driven by advancements in portable infusion technologies that enhance patient comfort and outcomes. This shift not only reduces the reliance on hospital admissions but also allows individuals with chronic diseases to receive their treatments in a familiar environment. The integration of telehealth services further supports this trend by enabling healthcare providers to remotely monitor patients, ensuring timely interventions and personalized care. As a result, the market is poised for growth, with increasing demand for innovative intravenous solutions that cater to the evolving needs of patients and healthcare systems.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Supply Chain Analysis
  • Pricing Analysis

Global Intravenous Solutions Market Size by Product & CAGR (2024-2031)

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Global Intravenous Solutions Market Size by Nutrients & CAGR (2024-2031)

  • Carbohydrates
  • Vitamins & Minerals
  • Single-dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

Global Intravenous Solutions Market Size & CAGR (2024-2031)

  • North America, (Product, Nutrients)
    • US
    • Canada
  • Europe, (Product, Nutrients)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Nutrients)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Nutrients)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Nutrients)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Akshar Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDEVAC LIFESCIENCES PVT LTD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LXIR MEDILABS PVT. LTD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aishwarya Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vifor Pharma Management Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JW Life Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amanta Health Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grifols S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AptarGroup, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sagent Pharmaceuticals, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제